Comparative Effectiveness of Angiotensin Receptor Blockers vs. Angiotensin-Converting Enzyme Inhibitors on Cardiovascular Outcomes in Patients Initiating Peritoneal Dialysis

BACKGROUND: There is evidence that angiotensin-converting enzyme inhibitors (ACEI) and angiotensin-II receptor blockers (ARB) may reduce cardiovascular (CV) risk in patients undergoing peritoneal dialysis (PD), but no studies have compared the effectiveness between these drug classes. In this observ...

Full description

Saved in:
Bibliographic Details
Published in:J Nephrol
Main Authors: Shen, Jenny I., Saxena, Anjali B., Montez-Rath, Maria E., Leng, Lynn, Chang, Tara I., Winkelmayer, Wolfgang C.
Format: Artigo
Language:Inglês
Published: 2016
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5446246/
https://ncbi.nlm.nih.gov/pubmed/27485007
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40620-016-0340-3
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items